Get startedLog in
    Picture of Infant Bacterial Therapeutics AB logo

    IBT B — Infant Bacterial Therapeutics AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Infant Bacterial Therapeutics Q4 Operating Loss Narrows To Sek 9.1 Mln

    Picture of Infant Bacterial Therapeutics AB logoInfant Bacterial Therapeutics AB
    28/02/2018 07:11
    Feb 28 (Reuters) - Infant Bacterial Therapeutics Ab 
 IBTb.ST : 
    * Q4 NET SALES SEK 0 VERSUS SEK 113,000 YEAR AGO 
    * Q4 OPERATING LOSS SEK 9.1 MILLION VERSUS LOSS SEK 14.1 
MILLION 
YEAR AGO 
    * BOARD PROPOSES NO DIVIDEND FOR FY 2017 
 
Source text for Eikon:  ID:nGNE6ZcynF  
Further company coverage:  IBTb.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Infant Bacterial Therapeutics AB

    See all news